Related Experiment Video

Updated: Aug 14, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.3K

DDX3: a relevant therapeutic target for lymphoma?

Marion Lacroix1,2, Hugues Beauchemin1, Tarik Möröy1,2,3

  • 1Hematopoiesis & Cancer Research Unit, Institut de recherches cliniques de Montréal, Montréal, QC, Canada.

Expert Opinion on Therapeutic Targets
|January 9, 2023
PubMed
Summary

No abstract available in PubMed .

Keywords:
B lymphomaDDX3XDDX3YRNA helicase

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

7.4K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.5K

Related Experiment Videos

Last Updated: Aug 14, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.3K
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

7.4K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

MIZ-1 controls transcriptional programs required for BCR signaling, actin dynamics, and naïve B cell survival.

Frontiers in immunology·2026

The lncRNA ELDR suppresses tumorigenicity of AML by interfering with DNA replication and chromatin accessibility.

Blood advances·2025

Inhibiting the RNA helicase DDX3X in Burkitt lymphoma induces oxydative stress and impedes tumor progression in xenografts.

Frontiers in cell and developmental biology·2025

GFI1B specifies developmental potential of innate lymphoid cell progenitors in the lungs.

Science immunology·2024

Conserved role of hnRNPL in alternative splicing of epigenetic modifiers enables B cell activation.

EMBO reports·2024

Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.

Blood·2023

The therapy-induced senescence-associated secretory phenotype and epithelial-mesenchymal transition axis in ovarian cancer: molecular mechanisms and therapeutic opportunities.

Expert opinion on therapeutic targets·2026

ACK family tyrosine kinases as potential therapeutic targets for cancer.

Expert opinion on therapeutic targets·2026

BCAA metabolic reprogramming identifies BCKDK as a therapeutic target in cancer.

Expert opinion on therapeutic targets·2026

Breakthroughs in our molecular understanding of therapeutic targets for pulmonary hypertension.

Expert opinion on therapeutic targets·2026

The PDPK1-RSK2 axis as a potential convergent therapeutic vulnerability in B-cell lymphomas.

Expert opinion on therapeutic targets·2026

APE1/Ref-1: multifunctional biology, selective inhibition, and the path to clinical translation.

Expert opinion on therapeutic targets·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us